CIK 0001826892 · Non-accelerated filer<br>Smaller reporting company
BioAtla, Inc.
Sign in to watch- Ticker
- BCAB
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851922320
- Phone
- 858-558-0708
- Business address
- 11085 TORREYANA ROAD, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 76 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-07-31 | Vasquez Christian See Remarks | Shares withheld for taxes | −194 | $2.99 | $580 | 101,744 |
| 2023-06-30 | GRAY MARY ANN Director | Grant or award | +4,916 | 22,726 | ||
| 2023-06-30 | Williams Eddie Director | Grant or award | +3,958 | 8,388 | ||
| 2023-06-30 | SHORT JAY M PHD Chief Executive Officer | Shares withheld for taxes | −2,888 | $3.00 | $9K | 1,400,835 |
| 2023-06-30 | Vasquez Christian See Remarks | Shares withheld for taxes | −194 | $3.00 | $582 | 101,938 |
| 2023-06-30 | Smith Scott Andrew Director | Shares withheld for taxes | −1,791 | $3.00 | $5K | 309,744 |
| 2023-06-30 | Sievers Eric Chief Medical Officer | Shares withheld for taxes | −555 | $3.00 | $2K | 90,527 |
| 2023-06-30 | WALDRON RICHARD A Chief Financial Officer | Shares withheld for taxes | −970 | $3.00 | $3K | 125,780 |
| 2023-06-14 | Smith Scott Andrew Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2023-06-14 | Smith Scott Andrew Director | Grant or award · Stock Option (Right to Buy) | +5,895 | 5,895 | ||
| 2023-06-14 | Williams Eddie Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2023-06-14 | Moran Susan Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2023-06-14 | STEINMAN LAWRENCE Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2023-06-14 | MCBRINN SYLVIA Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2023-06-14 | GRAY MARY ANN Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2023-05-31 | SHORT JAY M PHD Chief Executive Officer | Shares withheld for taxes | −2,888 | $3.15 | $9K | 1,403,723 |
| 2023-05-31 | WALDRON RICHARD A Chief Financial Officer | Shares withheld for taxes | −970 | $3.15 | $3K | 126,750 |
| 2023-05-31 | Sievers Eric Chief Medical Officer | Shares withheld for taxes | −554 | $3.15 | $2K | 91,082 |
| 2023-05-31 | Smith Scott Andrew Director | Shares withheld for taxes | −1,791 | $3.15 | $6K | 311,535 |
| 2023-05-31 | Vasquez Christian See Remarks | Shares withheld for taxes | −194 | $3.15 | $611 | 102,132 |
Page 6 of 11 · 212 trades